Singapore markets closed

Sumitomo Pharma Co., Ltd. (DNPUF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
2.2600-0.3550 (-13.58%)
At close: 03:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Total revenue
314,558,000
314,558,000
555,544,000
560,035,000
515,952,000
Cost of revenue
126,577,000
126,577,000
178,919,000
157,127,000
137,773,000
Gross profit
187,981,000
187,981,000
376,625,000
402,908,000
378,179,000
Operating expenses
Research development
112,637,000
112,637,000
131,858,000
94,903,000
132,682,000
Selling general and administrative
429,538,000
429,538,000
373,316,000
249,081,000
190,373,000
Total operating expenses
542,840,000
542,840,000
453,604,000
342,674,000
306,955,000
Operating income or loss
-354,859,000
-354,859,000
-76,979,000
60,234,000
71,224,000
Interest expense
4,277,000
4,277,000
3,159,000
3,050,000
2,586,000
Income before tax
-323,114,000
-323,114,000
-47,920,000
82,961,000
77,851,000
Income tax expense
-8,185,000
-8,185,000
48,794,000
42,361,000
41,022,000
Income from continuing operations
-314,929,000
-314,929,000
-96,714,000
40,600,000
36,829,000
Net income
-314,969,000
-314,969,000
-74,512,000
56,413,000
56,219,000
Net income available to common shareholders
-314,969,000
-314,969,000
-74,512,000
56,413,000
56,219,000
Basic EPS
-339.73
-792.79
-187.55
141.99
141.50
Diluted EPS
-339.73
-792.79
-187.55
141.99
141.50
Basic average shares
397,292
397,291
397,292
397,293
397,294
Diluted average shares
397,292
397,291
397,292
397,293
397,294